NEUROCHEMICAL AND NEUROGENETIC CORRELATES OF PARKINSONS-DISEASE
Citation
Y. Mizuno et al., NEUROCHEMICAL AND NEUROGENETIC CORRELATES OF PARKINSONS-DISEASE, Journal of neurochemistry, 71(3), 1998, pp. 893-902
Categorie Soggetti
Biology,Neurosciences
SICI code
0022-3042(1998)71:3<893:NANCOP>2.0.ZU;2-W
Abstract
We discuss neurochemical and neurogenetic correlates of Parkinson's di
sease (PD) based on the recent progress in the study of its etiology a
nd pathogenesis. Nigral degeneration with the presence of Lewy bodies
in the remaining neurons is the pathologic hallmark of PD, and the res
ultant loss of striatal dopamine is responsible for most of the clinic
al manifestations. Although the primary cause is still unknown, mitoch
ondrial respiratory failure and oxidative stress appear to be two majo
r contributors to the nigral cell death. Many endogenous and exogenous
compounds with structural similarity to MPTP have been postulated as
potential neurotoxins inducing nigral cell death in PD, but there is l
ittle evidence of accumulation of such compounds in the nigra. Genetic
influence has increasingly been recognized as an important risk facto
r for PD. In this respect, genetic linkage analysis and molecular clon
ing of the disease genes in familiar parkinsonism are of utmost import
ance today. Recently, the disease gene for one of the autosomal domina
nt forms of familial PD was identified, and we cloned the gene for an
autosomal recessive type of familiar parkinsonism that had been mapped
to the long arm of chromosome 6 by our group. Information obtained on
farnilial parkinsonism will contribute to the studies on sporadic PD
as well.